相关实验视频

Updated: May 9, 2025

Efficient Transfection of In vitro Transcribed mRNA in Cultured Cells Using Peptide-Poloxamine Nanoparticles

Efficient Transfection of In vitro Transcribed mRNA in Cultured Cells Using Peptide-Poloxamine Nanoparticles

Published on: August 17, 2022

推进针对传染病的mRNA疫苗:关键组件,创新和临床进展

Sha Li¹, Lu Zheng², Jingyi Zhong¹

¹Shanghai Pudong Hospital, Key Laboratory of Medical Molecular Virology (MOE/NHC/CAMS), School of Basic Medical Sciences, Shanghai Medical College, Fudan University, Shanghai, China.

Essays in biochemistry

|May 5, 2025

概括

使用脂质纳米粒子 (LNP) 的信使RNA (mRNA) 疫苗为传染病提供了快速发展的机会. 优化是克服不稳定性和改善未来疫苗进展的交付等挑战的关键.

科学领域:

疫苗学疫苗学疫苗学
分子生物学分子生物学
免疫学免疫学免疫学

背景情况:

使者RNA (mRNA) 疫苗技术已经彻底改变了传染病预防,正如COVID-19流行病所强调的那样.
这个平台利用病原体衍生的基因组序列来诱导抗原表达和随后的免疫反应.

研究的目的:

审查优化策略,临床进展和与mRNA疫苗开发相关的挑战.
提供对各种传染病mRNA疫苗技术未来进步的见解.

主要方法:

在体外转录的mRNA编码目标抗原.
在脂质纳米粒子 (LNP) 中封装mRNA用于细胞输送.
对各种mRNA候选疫苗的临床试验数据的分析.

主要成果:

针对COVID-19 (BNT162b2,mRNA-1273) 和RSV (mRNA-1345) 的mRNA疫苗的成功临床应用.
目前正在进行的流感,寨卡病毒和艾滋病毒的试验,自放大和多价值RNA疫苗的进展.
确定了挑战,包括mRNA不稳定性,超低温存储,LNP肝脏积累,以及在特定试验中的安全问题.

结论:

mRNA疫苗技术显示出显著的适应性和加速的开发时间表.
持续优化序列设计,输送系统 (如冷化,器官向) 和安全评估至关重要.
解决目前的障碍将进一步提高mRNA疫苗对更广泛的传染病的潜力.

关键词:

临床试验中的临床试验.传染病是一种传染性疾病.它们是mRNARNA.纳米颗粒是一种纳米粒子.疫苗,疫苗的使用情况.

更多相关视频

Synthesis and Characterization of mRNA-Loaded PolyBeta Aminoesters Nanoparticles for Vaccination Purposes

Synthesis and Characterization of mRNA-Loaded PolyBeta Aminoesters Nanoparticles for Vaccination Purposes

Published on: August 13, 2021

Optimization of In vitro Transcription Reaction for mRNA Production Using Chromatographic At-Line Monitoring

Optimization of In vitro Transcription Reaction for mRNA Production Using Chromatographic At-Line Monitoring

Published on: April 4, 2025

相关概念视频

Vaccinations

Vaccinations

Cancer Vaccines

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...

The Central Dogma

The Central Dogma

The central dogma explains the flow of genetic information from DNA nucleotides to the amino acid sequence of proteins.
RNA is the Missing Link Between DNA and Proteins
In the early 1900s, scientists discovered that DNA stores all the information needed for cellular functions and that proteins perform most of these functions. However, the mechanisms of converting genetic information into functional proteins remained unknown for many years. Initially, it was believed that a single gene is...

Viral Mutations

Viral Mutations

A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...